News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira     9/26/2016
New Setback Increases Sanofi (SNY)'s Hunger for a M&A     9/23/2016
Saga Continues for Sarepta (SRPT) as FDA Head Calls for Retraction of 'Misleading' 2013 Study     9/23/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again     9/23/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug     9/22/2016
Investors Beware: Thin CAR-T Data Could Make or Break Juno (JUNO) and Kite Pharma (KITE)     9/22/2016
Genentech (RHHBY) Gambles $310 Million+ on German Biotech BioNTech's mRNA Cancer Vaccine Tech     9/22/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected     9/22/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics     9/21/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Will Biogen (BIIB)’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?     9/20/2016
Another Good Day for Amgen (AMGN) as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints     9/20/2016

News from Around the Web
Researcher In Quest To Find A Cure For His Own Incurable Cancer     9/26/2016
Top Scientists Cautious About Fighting Cancer With Immunotherapy     9/26/2016
The Drug Industry Might Finally Have An Answer For Migraines     9/26/2016
What Does Fake Viagra Do To The Body? "World's Largest" Counterfeit Viagra Plant Discovered     9/26/2016
UVLrx Therapy Lights Up Charlatans Dealing In Medical Devices, UVLrx Therapeutics Reveals     9/26/2016
After Sarepta (SRPT)'s Win, BioMarin (BMRN) Wants a Piece of the Action Too     9/23/2016
Smoke Gets In Your Genes, National Institute of Environmental Health Sciences Study     9/23/2016
Medical Marijuana Seems To Reduce Deaths From Pharmaceuticals     9/23/2016
Stem Cell "Heart Patch" Closer To Reality, University of Wisconsin-Madison Study     9/23/2016
Sleep Well At 11 And Kick The Substances Out In Your Teens, University of Pittsburgh Study     9/22/2016
15 Cancer Causing Foods You Probably Eat Every Day     9/22/2016
Many Doctors Don't Prescribe Medication For Opioid Addiction Despite Epidemic     9/22/2016
Strawberry Flavour Increases Toxicity In E-Cigarettes, Roswell Park Cancer Institute Study     9/22/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
Surprise! Beer Makes You Happier, Friendlier, University Hospital in Basel Study     9/21/2016

Press Releases
Novartis AG (NVS) Receives Three New FDA Approvals For The Expanded Use Of Ilaris For Patients With Rare Periodic Fever Syndrome Conditions     9/26/2016
Janssen Biotech (JNJ) Release: FDA Approves STELARA (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease     9/26/2016
Janssen Biotech (JNJ) Release: FDA Approves STELARA (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease     9/26/2016
Bay Area's MicuRx Pharma Bags $55 Million to Develop Next-Generation Antibiotic     9/26/2016
Axovant (AXON) Receives FDA Fast-Track Designation For Intepirdine As An Investigational Treatment For Dementia With Lewy Bodies     9/26/2016
FDA Slaps Down Pain Therapeutics (PTIE)'s Remoxy for the Third Time, Stock Plummets     9/26/2016
GW Pharma (GWPH)'s Cannabis-Derived Drug Successful in Third Late-Stage Epilepsy Study     9/26/2016
Array BioPharma (ARRY) Rockets as Melanoma Drug Meets Endpoint in Phase III Study     9/26/2016
Achillion (ACHN) Announces 100% SVR12 In The 6-Week And 8-Week Cohorts In Janssen’s Phase II Trial Evaluating The Triple Combination Treatment Regimen Including Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-Naïve HCV     9/26/2016
Lipocine (LPCN) Announces Positive Top-Line Phase IIb Study Results For LPCN 1111, A Next Generation Oral Testosterone Replacement Therapy     9/26/2016
Galapagos (GLPG.BR) Release: Endoscopic Improvements With Filgotinib Are Consistent With Clinical Remission Rates In Patients With Crohn's Disease     9/26/2016
Summit Therapeutics Receives FDA Fast Track Status for DMD Treatment     9/26/2016
Dicerna (DRNA) Terminates Development of DCR-PH1, Shifts Focus     9/26/2016
AbbVie (ABBV) Announces Submission Of A Supplemental New Drug Application For Ibrutinib (IMBRUVICA) For Treatment Of Marginal Zone Lymphoma     9/26/2016
DURECT (DRRX)'s Licensee Pain Therapeutics (PTIE) Receives Complete Response Letter From FDA For REMOXY ER (Oxycodone) Extended-Release Capsules CII     9/26/2016

//-->